Bharat Immunological & Biological Corporation reports standalone net loss of Rs 3.87 crore in the September 2020 quarter

Image
Capital Market
Last Updated : Dec 31 2020 | 9:04 AM IST

Sales rise 213.09% to Rs 25.36 crore

Net Loss of Bharat Immunological & Biological Corporation reported to Rs 3.87 crore in the quarter ended September 2020 as against net loss of Rs 5.66 crore during the previous quarter ended September 2019. Sales rose 213.09% to Rs 25.36 crore in the quarter ended September 2020 as against Rs 8.10 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales25.368.10 213 OPM %-17.74-82.47 -PBDT-5.53-7.76 29 PBT-5.59-7.82 29 NP-3.87-5.66 32

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Dec 31 2020 | 8:08 AM IST

Next Story